Ozmosi | XW-10508 Drug Profile
Contact Us
Drug Profile
Using advanced filters...
Advanced Search [+]

XW-10508

Alternative Names: xw-10508, xw 10508, xw10508
Clinical Status: Active
Latest Update: 2025-01-10
Latest Update Note: Clinical Trial Update

Product Description

XW10508is an internally discovered, investigational, orally bioavailable, once-daily glutamatergic providing NMDA receptor inhibition and AMPA receptor activation in development for the intended treatment of MDD and chronic pain.

Mechanisms of Action: NMDA Antagonist, AMPA Activator

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Company: XW Laboratories
Company Location: Asia Pacific
Company Founding Year: None
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for XW-10508

Countries in Clinic: Australia

Active Clinical Trial Count: 2

Recent & Upcoming Milestones

Highest Development Phases

Phase 2: Depressive Disorder, Major

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

ACTRN12625000128493

 ACTRN12625000128493

P2

Not yet recruiting

Depressive Disorder, Major

2025-12-01

2026-02-15

Treatments

ACTRN12623001080617

 ACTRN12623001080617

P2

Recruiting

Depressive Disorder, Major

2024-08-30

2026-02-15

Treatments

Recent News Events

Date

Type

Title

09/08/2021

News Article

 XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain

06/14/2021

News Article

 XWPharma Announces Positive Results from Phase 1 Clinical Trials of XW10172, in Development as Once-Nightly Therapy for Sleep Disorders in Patients with Neurodegenerative Diseases

05/19/2021

News Article

 XWPharma Announces Abstract for XW10172 Accepted for Presentation at the Associated Professional Sleep Societies SLEEP 2021 Annual Meeting

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions